Increase in ER Visits, Hospital Admissions is Driven by Flu; IDPH Urges Public To Quickly Seek Testing and Treatment if they Experience Flu-like Symptoms The Illinois Department of Public Health (IDPH ...

Just a few months after Vir Biotechnology lost an emergency authorization for its COVID-19 antibody, Marianne de Backer ...

Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...

Palantir is gaining significant traction in the tech world with its AI-driven services, experiencing a dramatic stock ...

SHELTON, CT / ACCESS Newswire / February 11, 2025 / NanoViricides, Inc. (the "Company") declared today that it is ready to fight the bird flu with its revolutionary broad-spectrum antiviral drug ...

To offer further encouragement, Dame Emma Walmsley, the company’s chief, offered a more optimistic outlook than expected for 2025. The company steered expectations toward an increase of 3 to 5pc in ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Seven of 10 people with measles in Texas are hospitalized for a disease that was considered eliminated in 2000. Kennedy has ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Eliquis, a blood thinner marketed in partnership with Bristol Myers Squibb, is Pfizer's largest revenue stream at the moment.

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

ARM and Oracle are key AI bellwethers, reflecting market volatility and investor sentiment towards AI and tech stocks. Tariff threats under Trump create market uncertainty, but investors are ...